baber/WOPTO huggingface dataset:
Patent PT-1593804-E (PT)
Title: Corner transmission assembly with safety device against improper operation for tilt-and-turn wings of metallic window and door frames
Inventor: VINADIO AIMONE BALBO DI
IPC: E05D15/52
Filed: 2005-05-04
Abstract: A corner and safety transmission assembly for an actuating linkage of a metallic window or door frame with wing and swivel opening, comprising: 
- an "L" shaped guiding body (12) able to be fastened on the exterior of an upper corner of the movable frame of the window or door, 
- a first and a second slidable member (18, 20), mounted slidable on respective branches (14, 16) of the guiding body (12), 
- a flexible element (22) that interconnects said slidable members (18, 20) and 
- a safety block (46) including a body (52) in which is mounted a bolt (54) able to slide transversely relative to the direction of motion of the first slidable member (18) and against the action of elastic means (56).  The guiding body (12) has two transverse guides (50) between which is inserted the body (52) of the safety block (46). The first slidable member (18) has two segments (32, 34) with different heights and the body (52) of the safety block (46) has on one side oriented towards the guiding body (12) an opening directed in the longitudinal direction (64) engageable by the segment with greater height (32) of the slidable member (18) to prevent a motion in the transverse direction of the body (52) of the safety block (46).
Patent PT-1666481-E (PT)
Title: 3-((3r,4r)-4-methyl-3-[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor
Inventor: MUNCHHOF MICHAEL JOHN
IPC: A61P25/28
Filed: 2002-05-29
Abstract: The compound 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or a pharmaceutically acceptable salt thereof; compositions containing the compound; and uses of the compound in the manufacture of medicaments.
Patent PT-1773450-E (PT)
Title: Therapeutically combinations
Inventor: MESSADEK JALLAL
IPC: A61K9/22
Filed: 2005-07-13
Abstract: The goal of the present invention is a pharmaceutical composition including a betaine and an anti-cholesterol agent. The association and co-administration of at least a betaine allows to reducing side effects related to anti-cholesterol agents administration, in particular their deleterious effects on liver, pancreas and kidneys.
Patent PT-1813598-E (PT)
Title: Method for producing di- and polyamines of the diphenylmethane series
Inventor: MUELLER HEINZ-HERBERT
IPC: C07C209/78
Filed: 2007-01-16
Abstract: Preparation of di- and polyamines of diphenylmethane comprises reacting aniline (less than 3 wt.%) and formaldehyde in the presence of an acid catalyst.
Patent PT-1891973-E (PT)
Title: Combinations comprising antimuscarinic agents and pde4 inhibitors
Inventor: ESCARDO JORDI GRAS
IPC: A61K31/58
Filed: 2005-05-31
Abstract: Combination (I) comprises a phosphodiesterase inhibitor 4 (PDE4) (A) and an antagonist of M3 muscarinic receptors (B) (3(R)-(2-hydroxy-2, 2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo [2.2.2] octane), in the form of a salt having an anion X (anion of a mono or polyvalent acid). An independent claim is also included for a method of treating a patient suffering from or susceptible to a respiratory disease or condition which responds to M3 antagonism comprising simultaneous, concurrent, separate or sequential administration of (I). - ACTIVITY : Antiasthmatic; Respiratory-Gen.; Antiinflammatory. - MECHANISM OF ACTION : Phosphodiesterase-4 inhibitor; Muscarinic receptors antagonist; Leukotriene-D4 antagonist; Neurokinin-1- receptor antagonist; Epidermal growth factor receptor kinase inhibitor; Beta-2 agonist; p38 Kinase inhibitor.
Patent PT-2379095-E (PT)
Title: Compositions comprising lipophilic extracts of zingiber officinale and echinacea angustifolia for the prevention and treatment of gastro-oesophageal reflux
Inventor: BOMBARDELLI EZIO
IPC: A61K36/28
Filed: 2010-01-15
Abstract: The present invention relates to compositions consisting of a combination of lipophilic extracts of Zingiber officinale and Echinacea angustifolia, obtained by extraction with carbon dioxide under supercritical conditions, which are useful for the prevention and treatment of oesophageal reflux and chemotherapy-induced emesis.
Patent PT-563797-E (PT)
Inventor: NAKAMURA KO
IPC: G01N33/68
Filed: 1993-03-25
Abstract: Pyridinium derivatives of the present invention which are represented by the following formulae (I) or (II) <CHEM> wherein R and R' which may be same or different are alkyl groups optionally substituted by an amino group, a protected amino group and/or a carboxyl group, are suitable for conducting diagnosis of diabetes, diabetic complications, aging, diseases accompanied by same by using these compounds as an indicator. Moreover, it is possible to use the compounds of the invention for the preparation of an antibody being of similar diagnostic use.
Patent PT-732926-E (PT)
Inventor: HILLE THOMAS
IPC: A61K31/4425
Filed: 1994-12-06
Abstract: PCT No. PCT/EP94/04049 Sec. 371 Date Aug. 23, 1996 Sec. 102(e) Date Aug. 23, 1996 PCT Filed Dec. 6, 1994 PCT Pub. No. WO95/15756 PCT Pub. Date Jun. 15, 1995A pharmaceutical formulation for the prophylaxis and preliminary treatment of a poisoning caused by organophosphorus cholinesterase inhibitors is characterized in that it consists of an active substance combination of at least one parasympathomimetic and at least one parasympatholytic.
Patent PT-748319-E (PT)
Inventor: MALIGRES PETER E
IPC: C07D263/52
Filed: 1995-02-27
Abstract: A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.
Patent PT-721505-E (PT)
Inventor: MAERTENS GEERT
IPC: A61K39/395
Filed: 1995-07-31
Abstract: The present invention relates to monoclonal antibodies to purified recombinant HCV envelope proteins. During isolation of the recombinantly expressed protein a disulphide bond cleavage or reduction step is carried out with a disulphide bond cleavage agent; this is followed by a step preventing reformation of disulphide bridges. The present invention also relates to the diagnostic and therapeutic application of these monoclonal antibodies.
Patent PT-790824-E (PT)
Inventor: PILL JOHANNES
IPC: A61K31/20
Filed: 1995-11-09
Abstract: PCT No. PCT/EP95/04413 Sec. 371 Date Jul. 8, 1997 Sec. 102(e) Date Jul. 8, 1997 PCT Filed Nov. 9, 1995 PCT Pub. No. WO96/15784 PCT Pub. Date May 30, 1996Pharmaceutical agents for treating diabetus mellitus which contain a compound of formula I as the active substance, in which A, B, A' and W have the meanings stated in the claims, new compounds of formula I as well as processes for their production.
Patent PT-774333-E (PT)
Inventor: HEIMBUCHNER KLAUS
IPC: B29C33/10
Filed: 1996-11-16
Abstract: This vulcanisation mould (1) for tyre (14) mfr. has 600-3,000 air release holes (2). Each has a valve (3) so configured, that it is closed by the approaching tyre blank surface, to re-open again after vulcanisation, during tyre extraction. Pref. in each of the air release holes (2) is a valve (3)with moving insert (4), comprising valve rod (5) with an attached plate (6). The plate presents a frustrated conical section (7) towards the insert internal cavity. On the tyre surface side there is a plane surface (8). The conical surface mates with a valve seat surface (9) in the valve casing or in the surface of the mould (1) segment (10).
Patent PT-826485-E (PT)
Inventor: TRUJILLO JOSE SALCEDO
IPC: A43B13/14
Filed: 1996-08-24
Abstract: Applicable to those processes where a mould is used similar to those consisting of a receptacle with an upper lid (7); essentially characterized in that the receptacle of the mould is formed by two elements; a lower one or base (9) and an upper one or body (8) wherein its top volume defines a narrowing in such a way that the upper sole has in its side perimeter and its top area a curved-convex section (5). To remove the upper sole from the mould, the base (9) is removed which allows access to the lower part to remove the upper sole (2). The upper sole (2) of the invention is mounted on a sole (1), both forming the complete sole of the shoe. <IMAGE>
Patent PT-874581-E (PT)
Inventor: THOMAS JAMES M C
IPC: A61B5/026
Filed: 1996-11-26
Abstract: An apparatus for evaluating perfusion adjacent a skin surface includes a housing having first and second interior regions. The housing is configured to engage the skin surface. The apparatus also includes a plunger located in the first region of the housing for applying pressure to a first zone of the skin surface, a vacuum connection coupled to the second region of the housing to permit suction to be applied to the second region of the housing and to a second zone of the skin surface, a first temperature sensor for generating an output signal related to the temperature of the first zone of the skin surface, a second temperature sensor for generating an output signal related to the temperature of the second zone of the skin surface, and a processor circuit coupled to the first and second temperature sensors for determining a differential temperature between the first and second zones of the skin surface to provide an indication of perfusion adjacent the skin surface.
Patent PT-1009387-E (PT)
Inventor: BENJAMIN OSHLACK
IPC: A61K9/22
Filed: 1998-07-02
Abstract: A stabilized sustained release oral solid dosage form which includes an effective amount of tramadol or a pharmaceutically acceptable salt thereof dispersed in a matrix of a hydrophobic material comprising a wax-like substance which was melted or softened during the preparation of the matrix, is cured at a temperature from about 35° C. to about 65° C. for a time period from about 4 to about 72 hours, such that the formulation, when subjected to in-vitro dissolution after exposure to accelerated storage conditions of at least one month at 40° C./75% RH, releases an amount of tramadol which does not vary at any given dissolution time point by more than about 20% of the total amount of tramadol released when compared to in-vitro dissolution conducted prior to subjecting the dosage form to the accelerated storage conditions.
Patent PT-962240-E (PT)
Inventor: MARKKU KOIVUROVA
IPC: A63G13/08
Filed: 1999-05-21
Abstract: A spring articulation structure particularly for play, fitness training and sports instruments, said structure comprising a core element (1) supported in between two rubber rings (2) and provided with a shaft element (5) fitted in said core element; a shell compactly surrounding the core element and the rubber rings and attached to a bottom plate (9), the top part (3') of said shell being in the middle provided with a aperture (8) with a downwardly narrowing conical surface (7) for the shaft element (5); and a cylindrical element (4) resting on top of the top part (3') of the shell and surrounding the shaft element (5). <IMAGE>
Patent PT-1133596-E (PT)
Inventor: WAHLE BERND
IPC: D06M13/188
Filed: 1999-11-19
Abstract: An aqueous emulsion containing a hydrophobicizing composition, the composition containing: (a) a zirconium salt; and (b) a fatty compound selected from the group consisting of (i) branched or unbranched, symmetrical or nonsymmetrical dialkyl ethers having from about 8 to 44 carbon atoms, (ii) ester of branched or unbranched fatty acids having from about 12 to 22 carbon atoms with branched or unbranched fatty alcohols having from about 8 to 22 carbon atoms, (iii) branched or unbranched, symmetrical or nonsymmetrical dialkyl ketones having from about 8 to 44 carbon atoms, and mixtures thereof, and wherein the aqueous emulsion has an average particle size of from about 100 to 200 nm.
Patent SG-38992-G (SG)
Title: 2-azolylmethyl-3-difluorobenzyloxy-2,3-dihydrofluorobenzo(b)thiophenes,process for their preparation and compositions containing them
IPC: C07D409/06
Filed: 1992-04-07
Abstract: 2-Azolylmethyl-3-difluorobenzyloxy-2,3-dihydro-5- and 6-fluorobenzo [b]thiophen antifungal compounds, especially 2-(1H-imidazolylmethyl-3-(2',6'-difluorobenzyloxy)-2,3-dihydro-5-fluorobenzo[b]thiophene, pharmaceutical compositions containing them and their use in treating fungal infections in animals including humans are disclosed.
Patent IE-900046-L (IE)
Title: Pasty product dispenser
IPC: B65D47/26
Filed: 1990-01-05
Abstract: The dispenser for viscous products comprises a head (1) fixed to a body (100) or skirt (100) and a cap (2), this head (1) and this cap (2) comprising additional means (9, 19) of raising this cap (2) by the rotation of the said cap (2), this cap (2) having a central opening (14) and the head (1) comprising a stopper (3) carried by oblique lugs (4) fixed to the inside (5) of the head (1) and blocking this opening (14) in the low position of the cap (2), the head (1) and the cap (2) carrying additional sealing means (6, 15), characterised in that: a) the said sealing means consist of an internal skirt (15) of the cap (2) which inserts itself with a tightening action into the upper end of the head (1); b) and c) the oblique lugs (4) are fixed directly to the inside of the head (1), sufficiently low to liberate the engagement of the said internal skirt (15) in the head (1) during the operating of the cap (2). This dispenser is used in the pharmaceutical, cosmetic, hygiene and food fields. <IMAGE>
Patent IE-35098-L (IE)
Title: Storage container for celery
IPC: B65D43/04
Filed: 1971-01-25
Abstract: 1342641 Containers DART INDUSTRIES Inc 19 April 1971 [28 Jan 1970] 20498/71 Heading B8P A container assembly for supporting celery in a moist atmosphere comprises a container 11, a lid 12 to hermetically seal the container, and support ribs 25 extending above the base (14) of the container. The support ribs 25 are triangular in cross-section having their apexes upwards to reduce the area of contact with the celery, and may be integrally formed with the container or may comprise part of a removable tray 13 as shown. The tray 13 is supported in the container by integral downwardly extending flanges (27) and a ledge 30 formed in the container side walls 15. The tray 13 and container 11 have aligned recesses 32 and projections 31 respectively to facilitate removal of the tray. The container 11 is made of high and low density polyethylene blends or of polypropylene and the lid 12 of a low density polyethylene.
[GB1342641A]
Patent IE-36096-L (IE)
Title: Manufacture of sheet glass
IPC: C03B15/08
Filed: 1972-02-17
Abstract: Method making glass sheet by vertical drawing such that the pit below the glass being drawn is supplied continuously with a direct flow of molten glass, site being provided at which heat is supplied beneath the glass surface in the confines of the pit to create a thermal bearier formed by a current of ascending molten glass so that the molten glass present below the barrier is practically prevented by that part of the wall from passing under the barrier. The speed of drawing the glass may be increased without increasing the risk of corrosion and erosion of the refractory while producing glass free of ripples and similar imperfections.
[FR2126224A1]
Patent IE-780433-L (IE)
Title: N, n-diaryl-malonamide and diaryl methyl¹sulphinylacetamides.
IPC: A61K31/395
Filed: 1978-03-02
Abstract: Novel acetamide derivatives have been discovered to have useful pharmaceutical activity on the central nervous system. They may be prepared by reacting the corresponding ester or acid halide with the appropriately substituted amine.
[US4177290A]
Patent IE-820556-L (IE)
Title: Benzofurans
IPC: C07D409/06
Filed: 1982-03-11
Abstract: Compounds of formula (I): <IMAGE> (I) or a pharmaceutically acceptable salt thereof, wherein m is 0 to 3; n is 1 to 5; R1 is hydrogen, or C1-6 alkyl; R2 is hydrogen, C1-4alkyl, -(CH2)p-NH2 wherein p is 1 to 4, or -NHCOR, wherein R5 is C1-4 alkyl; R3 is hydrogen or C1-6 alkyl; R4 is C1-4alkyl, C1-4 alkoxy, halogen or CF3; and X is CH2 or S. having useful pharmacological activity, compositions containing them, and a process for their preparation.
[US4428940A]
Patent FI-830661-L (FI)
Inventor: SCHNEIDER CLAUS
IPC: A61K31/44
Filed: 1983-03-01
Abstract: Compounds of the formula    <IMAGE>  (I)  wherein R1 is amino, acetylamino, hydroxymethyl, methoxymethyl or   <IMAGE>  R2 and R3, which may be identical to or different from each other, are each hydrogen, fluorine, chlorine, bromine, trifluoromethyl, hydroxyl, methoxy, methyl or ethyl; R4 is straight or branched alkyl of 1 to 3 carbon atoms; and R5 and R6, which may be identical to or different from each other, are each hydrogen or alkyl of 1 to 4 carbon atoms or, together with each other and the nitrogen atom to which they are attached, form a 5-, 6- or 7-membered heterocyclic ring where, in the case of a 6-membered ring, a -CH2-group in the ring may be replaced by an oxygen atom, and non-toxic, pharmacologically acceptable salts thereof. The compounds as well as their salts are useful as antidepressants.
Patent FI-843670-L (FI)
Inventor: KUNG HSIANG-FU
IPC: C12N15/00
Filed: 1984-09-19
Abstract: A method for the extraction of intact recombinant human immune interferon with guanidine-HCl is disclosed. This method permits the purification to homogenity of intact recombinant human immune interferon.
Patent IE-36796-L (IE)
Title: Capsule-coated plastics film.
IPC: B29C59/10
Filed: 1971-09-30
Abstract: 1337140 Pressure sensitive record sheets FUJI PHOTO FILM CO Ltd 30 Sept 1971 [2 Oct 1970 27 Oct 1970 10 Nov 1970 (2) 30 Nov 1970 15 Dec 1970] 45664/71 Heading D2B [Also in Division B2] A capsule-coated sheet comprises a plastics film support having coated thereon a capsule layer, the plastics film having been subjected to at least one of the following treatments. (1) Corona discharge treatment, (2) flame treatment, (3) coating with a synthetic resin emulsion, (4) treatment by a liquid capable of swelling the plastics film or a mixture of such a liquid and a liquid not capable of swelling the film, and (5) coating with a fine granular solid material, before the application of the capsule layer, to reduce the contact angle of the surface of the film to less than 75‹. The synthetic resin emulsion in (3) may be emulsions of a vinyl acetate homopolymer, a vinyl chloride homopolymer, a vinylidene chloride homopolymer, an acrylic homopolymer, a styrene homopolymer, an ethylenic homopolymer, a butadiene homopolymer, an epoxy homopolymer, an amide homopolymer, a silicone homopolymer and copolymers thereof. Examples of the combinations of the plastics film and the swelling liquid are given. After treatment with the swelling liquid the plastics film may be treated with a non-swelling agent to coagulate the swelled surface portion to form a mat surface. Examples of the granular materials in (5) are given. They may be applied by coating or spraying a dispersion thereof in a swelling liquid for the plastics film, by coating on the plastics film a mixture of the granular material, a synthetic resin binder, and an organic solvent for the binder, or by coating on the film a mixture of the solid particles, and a hydrophilic polymer or a synthetic resin emulsion. The plastics films may be polyethylene, polypropylene, polyvinyl chloride, polystyrene, polyester, polyamide, polycarbonate or cellulose acetate. The preferred films are biaxially orientated. The capsules may be produced by (a) coacervation process from aqueous solution, (b) interfacial polymerisation, (c) polymerisation of monomer in oily droplets, (d) liquifying, dispersing and cooling waxy material, (e) spray drying, or (f) internal accumulation. In a typical Example a coacervate comprising a liquid membrane of gelatin and gum arabic formed around oily droplets containing crystal violet lactone was cooled to gel the liquid membrane and the wall mem branes hardened by adding formaldehyde solution, then aqueous sodium carboxymethyl cellulose and aqueous caustic soda. The temperature was then raised to 50‹C. and cellulose flock added to obtain a capsule liquid. Biaxially oriented polystyrene film was subjected to flame treatment to impart a contact angle of 45‹ thereto, and the support coated with the capsule liquid and dried to obtain a colourformer sheet for pressure-sensitive recording paper.
[GB1337140A]
Patent IE-791239-L (IE)
Title: Evaporative counterflow heat exchanger
IPC: F28D5/02
Filed: 1979-08-08
Abstract: A counterflow evaporative heat exchanger comprises a vertical conduit (10) in which a coil assembly (16) is positioned. A fluid to be cooled or condensed passes through the coil assembly (16) while water is sprayed downwardly over it and air is blown upwardly through it. The coil assembly (16) comprises a plurality of tubes (66) which at each level in the assembly are spaced apart from each other in the horizontal direction by an amount greater than the diameter of the tubes. This has been found to improve heat transfer in comparison to counterflow evaporative heat exchangers using closely packed coil assemblies.
Patent IE-821581-L (IE)
Title: Benzopyrazole derivative in cancer treatment
IPC: A61P35/00
Filed: 1982-06-30
Abstract: Treatment of different types of cancer by administer-this patei [AU8715682A]
Patent IE-36843-L (IE)
Title: Moving bed for hydrocarbon conversion.
IPC: B01J8/08
Filed: 1972-11-17
Abstract: 1408007 Discharging catalyst UNIVERSAL OIL PRODUCTS CO 17 Nov 1972 [18 Nov 1971] 53138/72 Heading B1F Catalyst is withdrawn from moving catalyst bed (17), (Fig. 2, not shown) in relatively equal amounts through uniformly distributed outlets (21), where it contacts a countercurrent hydrogen stream, to chambers 41, Fig. 6, of relatively equal volume formed by radial vertical partitions 25, the flow of catalyst to each chamber 41 automatically stopping when the level in the chamber reaches the discharge point of the respective conduits 22. The flow of catalyst through outlets 21 is stopped e.g. by increasing the upward flow of hydrogen through conduits 22 when catalyst is discharged from chambers 41 through the bottom outlet of collector 23. The catalyst can be withdrawn from the beds 17 while the reactor containing them is maintained in an onstream condition for reforming hydrocarbons.
[GB1408007A]
Patent IE-821629-L (IE)
Title: Generation of electrical energy using wind power
IPC: F03D9/00
Filed: 1982-07-06
Abstract: A method for utilizing wind energy for electricity production based on a wind motor and an auxiliary direct current electric motor coupled by an angular speed summation mechanism to an alternating current electric generator maintained at constant speed. The generator can be connected to a power grid or can supply local user appliances by means of a circuit to which other constant frequency generators are either connected or not. If connected to the power grid or to other generators, electricity can be produced at constant frequency by the wind with high efficiency by modulating the power supplied by the auxiliary electric motor. In the case of isolated operation, a low priority user appliance which can be modulated over a certain range has also to be provided in order to produce wind electricity under optimum conditions.
[US4556801A]
Patent IE-791856-L (IE)
Title: Jack-up platform structure
IPC: E02B17/08
Filed: 1979-09-28
Abstract: An off-shore platform of the self-erecting type has a floating deck provided with legs which can be raised and lowered and on which the platform is jacked up after they rest on a base structure placed onto the ocean floor. Each of the legs is guided within the deck in two vertically spaced bearings, the upper one of which is universally yieldable so that the leg can pivot about a center point of this bearing and the lower one of which is yieldable only in radial direction and provided with an annular space surrounding the leg and into which compressible or incompressible flowable medium can be introduced at will so as to allow the bearing either to yield or else to prevent it from yielding.
[US4318640A]